70. Yuan G., Wang J., Hegele RA. Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease. CMAJ. 2006 Apr 11; 174 (8): 1124-9.
71. Goldberg AC., Hopkins PN, Toth PP, Ballantyne CM, Rader DJ, Robinson JG, Daniels SR, Gidding SS, de Ferranti SD, Ito MK, McGowan MP, Moriarty PM, Cromwell WC, Ross JL, Ziajka PE; National Lipid Association Expert Panel on Familial Hypercholesterolemia. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adultpatients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011 Jun; 5 (3 Suppl): S1-8. doi:10.1016/j.jacl.2011.04.003. Epub 2011 Apr 12.
72. Civeira F. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis. 2004 Mar; 173 (1): 55–68.
73. Кухарчук В. В., Малышев П. П., Мешков А. Н. Семейная гиперхолестеринемия: современные аспекты диагностики, профилактики и терапии. Кардиология. 2009; 49 (1): 76–83.
74. Yuan G, Wang J., Hegele RA. Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease. CMAJ. 2006 Apr 11; 174 (8): 1124-9.
75. Hopkins PN, Toth PP, Ballantyne CM, Rader DJ Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on FamilialHypercholesterolemia. J Clin Lipidol. 2011 Jun; 5 (3 Suppl): S9-17.
76. Myant NB. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia. Atherosclerosis. 1993 Dec; 104 (1–2): 1-18.
77. Merino-Ibarra E., Castillo S., Mozas P., Cenarro A., Martorell E., Díaz JL, Suarez-Tembra M., Alonso R., Civeira F., Mata P., Pocoví M.. Screening of APOB gene mutations in subjects with clinical diagnosis of familialhypercholesterolemia. Hum Biol. 2005 Oct; 77 (5): 663-73.
78. Soufi M., Sattler AM, Maerz W., Starke A., Herzum M., Maisch B., Schaefer JR. A new but frequent mutation of apoB-100-apoB His3543Tyr. Atherosclerosis. 2004 May; 74 (1): 11.
79. Burnett JR, Hooper AJ. Common and rare gene variants affecting plasma LDL cholesterol. Clin Biochem Rev. 2008 Feb; 29 (1): 11-2.
80. Мандельштам, М. Ю., Васильев В. Б. Моногенные гиперхолестеринемии: новые гены, новые мишени для лечения. Генетика. – 2008. – Т. 44, N 10. – С. 1309–1316.
81. Maxwell KN, Fisher EA, Breslow JL. Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment. Proc Natl Acad Sci USA. 2005 Feb 8; 102 (6): 2069-74.
